Publish date: 11 October 2022

Mental Health Research Centre Recruits for OCD Drug Trial

A Swindon-based clinical research unit is looking for adults aged 18-65 with a diagnosis or experiencing symptoms of obsessive-compulsive disorder (OCD), to be involved in an exciting new research opportunity.

The Kingshill Research Centre, which is run by Avon and Wiltshire Mental Health Partnership (AWP) NHS Trust and located at the Victoria Centre on the Great Western Hospital site, is studying a new drug to help treat the symptoms of OCD.

As part of the study, the Kingshill Research Centre will be understanding the effects of Troriluzole on OCD symptoms. Troriluzole, is currently used to treat sclerosis, and has been considered to show potential benefit for people with OCD.

Dr Muthukrishnan, Consultant Psychiatrist and Principal Investigator at the Kingshill Research Centre, said: “First-line treatment for OCD currently includes cognitive behaviour therapy and anti-depressant medications. Research has shown that 60% of people with OCD do not have a very good response to these treatments, so this new study is a great step forward in finding new treatment options for people with OCD”.

Kate Hodson, Mental Health Research Nurse added: “This 12-week study is looking to recruit adults who have a diagnosis or  symptoms of OCD for more than a year and are not satisfied with their current treatment. During the study, seven sessions in total, tests and assessments will be completed, including blood and urine tests.”

The Kingshill Research Centre has worked with major pharmaceutical companies on successful trials for more than 28 years. If you would like more information about the current OCD study and how to be involved in the research, please contact the team on 01793 327 954 or email: